Laboratoire français de Fractionnement et de Biotechnologies

Biotech

Pipeline Programs↗

Distinct drugs in development (Preclinical–Phase 3)

Indications↗

Distinct diseases across all programs

Clinical Trials↗

All sponsored trials (all statuses)

Orange Book Patents

Across 1 drug with upcoming expirations

Activity

Recent Activity

Last 14 days

Nov 5, 2026

No longer available

HEMOLEVEN® Expanded Access Program Prevention of Surgical/Postpartum Hemorrhage Severe Inherited Factor XI Deficiency

Earlier

Aug 1, 2026TrialA Phase 3 Study of the Safety and Efficacy of Coagulation Factor VIIa (Recombinant) for the Prevention of Excessive Bleeding in Patients With Congenital Hemophilia A or B With Inhibitors to Factor VIII or IX Undergoing Elective Major Surgical Procedures

May 15, 2025FDAAlbumin — PACLITAXEL

May 9, 2025FDAAlbumin — OPTISON

Dec 1, 2023FDAAlbumin — TECHNETIUM TC 99M ALBUMIN AGGREGATED KIT

Nov 7, 2023TrialRetrospective Experience Assessing the Real-World Utilization and Effectiveness of SEVENFACT®

Aug 25, 2023FDAAlbumin — MEGATOPE

Aug 25, 2023FDAAlbumin — PULMOTECH MAA

3 more events

Jul 27, 2022FDAAlbumin — PACLITAXEL

Sep 16, 2021FDAAlbumin — OPTISON

Sep 1, 2021FDAAlbumin — OPTISON

Details

Company Info

Company Overview

—

Mkt Cap

—

Revenue

—

Cash

Patent Expirations

3 patent groups across drugs · Source: FDA Orange Book

DrugExpires

EllaDec 8, 2028 EllaFeb 20, 2029 Ella6 patentsApr 13, 2030

Regulatory

Regulatory Timeline

20153 events

FDAMay 11

Albumin — TECHNETIUM TC 99M ALBUMIN AGGREGATED KIT

Application BLA017881

FDAApr 7

Ella — ELLA

Application NDA022474

FDAMar 10

Ella — ELLA

Application NDA022474

20165 events

FDASep 16

Albumin — OPTISON

Application NDA020899

FDASep 16

Albumin — OPTISON

Application NDA020899

FDAJun 9

Albumin — TECHNETIUM TC 99M ALBUMIN AGGREGATED KIT

Application BLA017881

FDAApr 15

Albumin — OPTISON

Application NDA020899

FDAMar 1

Albumin — TECHNETIUM TC 99M ALBUMIN AGGREGATED KIT

Application BLA017881

20171 event

FDAOct 20

Albumin — TECHNETIUM TC 99M ALBUMIN AGGREGATED KIT

Application BLA017881

20181 event

FDAMay 1

Ella — ELLA

Application NDA022474

20201 event

FDAMar 20

Albumin — PULMOTECH MAA

Application BLA210089

20213 events

FDASep 16

Albumin — OPTISON

Application NDA020899

FDASep 1

Albumin — OPTISON

Application NDA020899

FDAJun 24

Ella — ELLA

Application NDA022474

20221 event

FDAJul 27

Albumin — PACLITAXEL

Application NDA211875

20233 events

FDADec 1

Albumin — TECHNETIUM TC 99M ALBUMIN AGGREGATED KIT

Application BLA017881

FDAAug 25

Albumin — MEGATOPE

Application BLA017837

FDAAug 25

Albumin — PULMOTECH MAA

Application BLA210089

20252 events

FDAMay 15

Albumin — PACLITAXEL

Application ANDA216355

FDAMay 9

Albumin — OPTISON

Application NDA020899

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)